Research
Hormonal
GLP-1 receptor agonists (GLP-1RAs) have transformed the management of obesity and provide unprecedented efficacy and acceptable safety in weight reduction and glycemic control.
Practitioners can consider GLP-1RAs as effective options for managing obesity and glycemic control in patients.
StrongSupportsmedium confidence
These drugs not only provide unprecedented efficacy and acceptable safety in weight reduction and glycemic control for patients with obesity and Type 2 diabetes.
Why this rating
The claim is based on a narrative review of existing therapies and their outcomes.
Source
Harnessing GLP‐1 Receptor Agonists for Obesity Treatment: Prospects and Obstacles on the Horizon
Riad Mohammed Abdelrahman et al. · Journal of Obesity · 2025
reviewCited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →